Boston, MA -- (SBWIRE) -- 01/17/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Flextronics International Ltd.(NASDAQ:FLEX), Polycom Inc(NASDAQ:PLCM), YRC Worldwide, Inc.(NASDAQ:YRCW), Generex Biotechnology Corporation(OTCMKTS:GNBT)
Flextronics International Ltd.(NASDAQ:FLEX) opened its shares at the price of $7.86 for the day. Its closing price was $7.84 after losing -0.13% for the day. The company traded with the total volume of 4.54 million shares, while its average trading volume remained 4.72 million shares. The beta of FLEX stands at 1.92. Flextronics International Ltd. provides design and manufacturing services to original equipment manufacturers (OEMs) worldwide.
Has FLEX Found The Bottom and Ready To Move Up? Find Out Here
Polycom Inc(NASDAQ:PLCM) percentage change plunged -2.01% to close at $11.73 with the total traded volume of 4.51 million shares, and average volume of 1.66 million. The 52 week range of the stock remained $9.00 - $12.11, while its day lowest price was $11.63 and it hit its day highest price at $12.06. Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration.
Has PLCM Found The Bottom And Ready To Gain Momentum? Find Out Here
YRC Worldwide, Inc.(NASDAQ:YRCW) started its trading session with the price of $14.00 and closed at $15.47 by scoring +21.05%. YRCW’s stocks traded with total volume of 4.37 million shares, while the average trading volume remained 1.88 million shares. The beta of YRCW stands at 3.28. Day range of the stock was $13.93 -$15.86. YRC Worldwide Inc., through its subsidiaries, provides various transportation services primarily in North America.
Will YRCW Continue To Move Higher? Find Out Here
Generex Biotechnology Corporation(OTCMKTS:GNBT) ended its day with the loss of -1.18% and closed at the price of $0.0420 after opening at $0.04. Stock traded during its last trading session with the total volume of 4.11 million shares, as compared to its average volume of 5.57 million shares. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.
Will GNBT Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)